Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity.
Burney
I A
IA
Siddiqui
T
T
Siddiqui
I
I
D000368:Aged; D000995:Antitubercular Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D018394:CA-125 Antigen / Q000097:blood*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000097:blood; D014397:Tuberculosis, Pulmonary / Q000097:blood* / Q000188:drug therapy
D000995:Antitubercular Agents; D015415:Biomarkers; D018394:CA-125 Antigen